APA (7th ed.) Citation

Kechin, A., Borobova, V., Kel, A., Ivanov, A., & Filipenko, M. (2022). ErbB4 Is a Potential Key Regulator of the Pathways Activated by NTRK-Fusions in Thyroid Cancer. Applied Sciences (2076-3417), 12(5), 2506. https://doi.org/10.3390/app12052506

Chicago Style (17th ed.) Citation

Kechin, Andrey, Viktoriya Borobova, Alexander Kel, Anatoliy Ivanov, and Maxim Filipenko. "ErbB4 Is a Potential Key Regulator of the Pathways Activated by NTRK-Fusions in Thyroid Cancer." Applied Sciences (2076-3417) 12, no. 5 (2022): 2506. https://doi.org/10.3390/app12052506.

MLA (9th ed.) Citation

Kechin, Andrey, et al. "ErbB4 Is a Potential Key Regulator of the Pathways Activated by NTRK-Fusions in Thyroid Cancer." Applied Sciences (2076-3417), vol. 12, no. 5, 2022, p. 2506, https://doi.org/10.3390/app12052506.